SREBF1 and colorectal carcinoma: This is in parallel with our finding that TYM-3-98 can inhibit CRC by inducing ferroptosis through suppression of SREBP1 and its downstream targets, and that overexpression of SREBP1 attenuated the efficacy of TYM-3-98 (Fig. 5).